Arjo AB (publ)

Research Arjo AB (publ) (ARJO-B) on Bullrun: valuation model: 12.2% undervalued, market cap SEK 6.77B, P/E 19.3, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerARJO-B
• ExchangeST
• CountrySweden
• SectorHealthcare
• IndustryMedical Distribution
• CurrencySEK
• Valuation signal12.2% undervalued
• Market capSEK 6.77B
• P/E19.3
• Dividend yield3.8%
• Financial periodFY2024
• RevenueSEK 11.29B
• Revenue growth2.8%
• Net incomeSEK 498.00M
• Free cash flowSEK 1.12B
• Gross margin43.5%

Valuation Snapshot

Bullrun's latest valuation model marks Arjo AB (publ) as 12.2% undervalued; latest market cap is SEK 6.77B; P/E is 19.3; dividend yield is 3.8%.

About Arjo AB (publ)

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, hygiene, prevention of pressure injuries and blood clots, and leg ulcer treatment and prevention, as well as for obstetric and cardiac diagnostics.

Frequently asked questions

Is Arjo AB (publ) overvalued or undervalued?

Bullrun's valuation model currently marks Arjo AB (publ) as 12.2% undervalued.

What is Arjo AB (publ)'s market cap?

Arjo AB (publ)'s market capitalization is SEK 6.77B.

What is Arjo AB (publ)'s P/E ratio?

Arjo AB (publ)'s price-to-earnings (P/E) ratio is 19.3.

Does Arjo AB (publ) pay a dividend?

Arjo AB (publ) has a dividend yield of 3.8%.

What does Arjo AB (publ) do?

Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and the Pacific.